Sign in

CIK 0001420565

  • Non-accelerated filer
  • Smaller reporting company

Rein Therapeutics, Inc.

Sign in to watch
Ticker
RNTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
134196017
Phone
+1 737-802-1989
Business address
12407 N. MOPAC EXPY., SUITE 250 #390, AUSTIN, TX, 78758
Former names
Aileron Therapeutics, Inc., AILERON THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2017-07-05 Shanafelt Armen Director Conversion · Series D Preferred Stock −3,390,885 0
2017-07-05 Shanafelt Armen Director Conversion · Series E-2 Preferred Stock −1,907,373 0
2017-07-05 Shanafelt Armen Director Conversion · Series E-3 Preferred Stock −1,654,411 0
2017-07-05 Shanafelt Armen Director Conversion · Series F Preferred Stock −1,443,972 0
2017-07-05 LV Management Group, LLC Former 10% owner Conversion +844,987 844,987
2017-07-05 LV Management Group, LLC Former 10% owner Purchase +250,000 $15.00 $3.8M 1,094,987
2017-07-05 LV Management Group, LLC Former 10% owner Conversion · Series D Preferred Stock −3,390,885 0
2017-07-05 LV Management Group, LLC Former 10% owner Conversion · Series E-2 Preferred Stock −1,907,373 0
2017-07-05 LV Management Group, LLC Former 10% owner Conversion · Series E-3 Preferred Stock −1,654,411 0
2017-07-05 LV Management Group, LLC Former 10% owner Conversion · Series F Preferred Stock −1,443,972 0
2017-07-05 AJU IB Investment Co., Ltd. 10% owner Conversion +443,973 443,973
2017-07-05 AJU IB Investment Co., Ltd. 10% owner Conversion +48,656 492,629
2017-07-05 AJU IB Investment Co., Ltd. 10% owner Purchase +24,929 $15.00 $374K 517,558
2017-07-05 AJU IB Investment Co., Ltd. 10% owner Conversion · Series E-3 Preferred Stock −4,411,765 0
2017-07-05 AJU IB Investment Co., Ltd. 10% owner Conversion · Series F Preferred Stock −483,501 0
2017-07-05 Gallagher Brian M. Jr. Director Conversion +1,158,186 1,158,186
2017-07-05 Gallagher Brian M. Jr. Director Purchase +273,333 $15.00 $4.1M 1,431,519
2017-07-05 Gallagher Brian M. Jr. Director Conversion · Series D Preferred Stock −6,781,770 0
2017-07-05 Gallagher Brian M. Jr. Director Conversion · Series E-2 Preferred Stock −1,471,551 0
2017-07-05 Gallagher Brian M. Jr. Director Conversion · Series E-3 Preferred Stock −1,276,389 0

Page 13 of 16 · 320 trades